Send me a link:

*Text messaging rates may apply.

 Dow Up 0.47% Nasdaq Up 0.63%

Neogenomics Inc. (NEO)

-NasdaqCM
4.17 Down 0.03(0.71%) Jul 9, 4:00PM EDT
|After Hours : 4.22 Up 0.05 (1.23%) Jul 9, 4:02PM EDT
Prev Close:4.20
Open:4.19
Bid:4.18 x 100
Ask:N/A
1y Target Est:6.50
Beta:1.64
Next Earnings Date:17-Jul-14NEO Earnings announcement
Day's Range:4.09 - 4.39
52wk Range:2.05 - 4.69
Volume:481,917
Avg Vol (3m):305,450
Market Cap:207.18M
P/E (ttm):101.71
EPS (ttm):0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NEO

Comparison

Symbol% ChgMkt Cap
NEODown 0.71%207.18M
LHUp 0.54%8.86B
MYGNUp 1.75%2.82B

Key Statistics

Forward P/E (1 yr):46.33
P/S (ttm):3.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.04
Quarterly EPS Est (Jun-14) :0.01
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):5.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback